Dalin Li
Cedars-Sinai Medical Center
Appearances
- DateMay 7, 2023The pathogenesis of inflammatory bowel disease (IBD) involves crosstalk between genetic and microbial factors that influence immune reactions. Tofacitinib, a pan JAK-STAT inhibitor, is a small molecule indicated for the treatment of moderate-to-severe ulcerative colitis (UC)…
Presenter
Cedars-Sinai Medical CenterSpeakers
Cedars-Sinai Medical Center - DateMay 9, 2023INTRODUCTION: We aimed to investigate the relationship between consumption of ultra-processed foods (UPFs) and: 1) active symptomatic disease and 2) intestinal inflammation in a cohort of adults living with inflammatory bowel disease (IBD)…
Presenter
Speakers
Cedars-Sinai Medical CenterCedars-Sinai Medical Center - DateMay 9, 2023INTRODUCTION: We aimed to investigate the relationship between consumption of ultra-processed foods (UPFs) and: 1) active symptomatic disease and 2) intestinal inflammation in a cohort of adults living with inflammatory bowel disease (IBD)…
Presenter
Speakers
Cedars-Sinai Medical CenterEmory UniversityUniversity of Miami Miller School of MedicineCedars-Sinai Medical CenterCedars-Sinai Medical Center - DateMay 9, 2023BACKGROUND: Cancer is a major cause of morbidity and mortality in persons with inflammatory bowel disease (IBD). We evaluated temporal trends and relative risks of intestinal and extra-intestinal cancers among persons with IBD and matched controls…
Presenter
Speakers
Cedars-Sinai Medical CenterCedars-Sinai Medical CenterCedars-Sinai Medical Center - DateMay 19, 2024BACKGROUND: Although incidence of Inflammatory Bowel Disease (IBD) is rising in underrepresented populations, including Hispanics, genetic studies of IBD have primarily focused on Northern European ancestral populations…
Presenter
Speakers
Cedars-Sinai Medical CenterCedars-Sinai Medical CenterUniversity of Miami Miller School of MedicineIcahn School of Medicine at Mount SinaiCedars-Sinai Medical Center - DateMay 19, 2024BACKGROUND: With the comprehensive characterization of 14,287 primary genetic association with 2,923 plasma proteins in 54,219 UKBB participants, the recently published UKBB pQTL dataset provides a rich resource to elucidate the biological mechanisms underlying proteo-genomic discoveries and accele…
Presenter
Cedars-Sinai Medical CenterSpeaker
Cedars-Sinai Medical Center - DateMay 19, 2024Genetic and environmental influences contribute to Crohn’s disease (CD) development. However, the relationship between these two factors is unclear, limiting insights into CD pathophysiology, as well as interventions to prevent disease…
Presenter
Rutgers Robert Wood Johnson Medical SchoolSpeakers
Cedars-Sinai Medical CenterCedars-Sinai Medical Center - DateMay 18, 2024BACKGROUND: Previously we identified that patients with initial diagnosis of Ulcerative Colitis (UC) but subsequently had a diagnosis change to Crohn’s Disease (CD) (UC2CD) are a unique IBD subgroup with distinct serological, genetic and clinical features, including non-response to anti-TNF treatme…
Presenter
Cedars-Sinai Medical CenterSpeakers
- DateMay 18, 2024SOCIETY: AGA This session highlights the latest research on novel prediction models in IBD as well as the role of the fecal microbiome and imaging in IBD…
Moderators
University of California San FranciscoUniversite de MontrealSpeakers
Icahn School of Medicine at Mount Sinai Department of PediatricsCedars-Sinai Medical Center - DateMay 3, 2025This session will discuss novel findings in IBD genetics in different populations, including large scale exome sequencing and the effect of ancestry on the genetic make up in IBD…
Moderators
University Hospitals LeuvenCedars-Sinai Medical Center